Additional file 6. Bioactivities, cytotoxicities and Tanimoto similarities of the Cluster set
Additional file 6: Figure S4. 791, 833 or 892 do not alter the half-life of HIV-1 Tat relative to DM...
Additional file 6: Figure S4. Effect of various compounds on HeLa cell number transfected with diffe...
Additional file 5: Figure S3. Characterization of HeLa rtTA HIVGagGFP cell line. a Representative im...
Additional file 5. Bioactivities, cytotoxicities and Tanimoto similarities of the Diverse set
Additional file 7. Cluster centers and distribution of physicochemical properties of hSGLT1 active c...
Additional file 2. Schematic overview of the experimental workflow of this study
Additional file 5: Table S4. Data distribution of training set, testing set and external validation ...
Additional file 1: Table S1. 10-fold cross-validation results of different machine learning methods ...
Additional file 3: Table S2. Importance and P value of top 10 chemical structure descriptors
Additional file 9: Table S7. Information of crystal structure used for descriptor generation
Additional file 10: Table S8-1. Sequence similarity descriptors based on 30 NR proteins (T1). Table ...
Additional file 11: Table S9-1. Sequence similarity descriptors based on 5 NR proteins (T3). Table S...
Additional file 4: Table S3. Model performance of random forest classifier on four protein descripto...
Additional file 4: Table S1. Partial biomarker proteins identified in each inhibitor-treated group
potentially active compounds. analyses suggest rational models to identify Microtubule inhibitors: s...
Additional file 6: Figure S4. 791, 833 or 892 do not alter the half-life of HIV-1 Tat relative to DM...
Additional file 6: Figure S4. Effect of various compounds on HeLa cell number transfected with diffe...
Additional file 5: Figure S3. Characterization of HeLa rtTA HIVGagGFP cell line. a Representative im...
Additional file 5. Bioactivities, cytotoxicities and Tanimoto similarities of the Diverse set
Additional file 7. Cluster centers and distribution of physicochemical properties of hSGLT1 active c...
Additional file 2. Schematic overview of the experimental workflow of this study
Additional file 5: Table S4. Data distribution of training set, testing set and external validation ...
Additional file 1: Table S1. 10-fold cross-validation results of different machine learning methods ...
Additional file 3: Table S2. Importance and P value of top 10 chemical structure descriptors
Additional file 9: Table S7. Information of crystal structure used for descriptor generation
Additional file 10: Table S8-1. Sequence similarity descriptors based on 30 NR proteins (T1). Table ...
Additional file 11: Table S9-1. Sequence similarity descriptors based on 5 NR proteins (T3). Table S...
Additional file 4: Table S3. Model performance of random forest classifier on four protein descripto...
Additional file 4: Table S1. Partial biomarker proteins identified in each inhibitor-treated group
potentially active compounds. analyses suggest rational models to identify Microtubule inhibitors: s...
Additional file 6: Figure S4. 791, 833 or 892 do not alter the half-life of HIV-1 Tat relative to DM...
Additional file 6: Figure S4. Effect of various compounds on HeLa cell number transfected with diffe...
Additional file 5: Figure S3. Characterization of HeLa rtTA HIVGagGFP cell line. a Representative im...
DOI
Add to ORKG